T. Uguen, B. Leconte, R. Desgrippes, B. Tchoundeu, J. François Bretagne, and S. Manfredi, “First description of an uterine perforation potentially imputable to treatment with bevacizumab”, AO, vol. 51, no. 8, pp. 1102–1104, Nov. 2012.